Alphabet Inc’s Parabilis Medicines Inc PBLS Stock Holding History

Alphabet Inc’s Portfolio PBLS Stock Details PBLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$159M	Hold	4,919,498	–	–	0.18%	9
2026 Q2	$135M	Buy	+4,919,498	New	+$136M	0.14%	8

Other funds holding PBLS

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Regeneron Pharmaceuticals Tarrytown, New York $180M AUM 18.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $134B AUM 35.21% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Matisse Capital Portland, Oregon $256M AUM 15.28% 1-Year Est. Return

Alphabet Inc's PBLS Position: Q3 2026 in Review

Alphabet Inc held its Parabilis Medicines Inc (PBLS) position steady in Q3 2026 at 4,919,498 shares worth $159M. The position accounts for 0.18% of the portfolio, ranked #9.

Alphabet Inc first reported a position in PBLS in Q2 2026 and has held it in 2 quarters since. 45 funds tracked by Wall St. Rank hold PBLS as of Q3 2026.

Alphabet Inc held 4,919,498 shares of Parabilis Medicines Inc worth $159M as of Q3 2026.
Alphabet Inc left its Parabilis Medicines Inc share count unchanged in Q3 2026.
Parabilis Medicines Inc made up 0.18% of Alphabet Inc's portfolio in Q3 2026, its #9 holding.
Alphabet Inc first reported a position in Parabilis Medicines Inc in Q2 2026 and has held it in 2 quarters since.
45 funds tracked by Wall St. Rank held Parabilis Medicines Inc as of Q3 2026.

Based on Alphabet Inc's 13F filing for Q3 2026, filed 6 Nov 2026.